Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SATRALIZUMAB: Safety Overview

Metric SARGRAMOSTIM SATRALIZUMAB
Total FAERS Reports 593 219
Deaths Reported 85 16
Death Rate 14.3% 7.3%
Hospitalizations 138 108
Average Patient Age 34.4 yrs 51.6 yrs
% Female Patients 43.5% 82.1%
Manufacturer Partner Therapeutics, Inc. Genentech, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription